Abstract
INTERLEUKIN-5 (IL-5) is a lineage-specific cytokine for eosinophilpoiesis and plays an important part in diseases associ-ated with increased eosinophils, such as asthma1,2. Human IL-5 is a disulphide-linked homodimer with 115 amino-acid residues in each chain2. The crystal structure at 2.4 Å resolution reveals a novel two-domain structure, with each domain showing a striking similarity to the cytokine fold found in granulocyte macrophage3 and macrophage4 colony-stimulating factors, IL-2 (ref. 5), IL-4 (ref. 6), and human7 and porcine8 growth hormones. IL-5 is unique in that each domain requires the participation of two chains. The IL-5 structure consists of two left-handed bundles of four helices laid end to end and two short β-sheets on opposite sides of the molecule. Surprisingly, the C-terminal strand and helix of one chain complete a bundle of four helices and a β-sheet with the N-terminal three helices and one strand of the other chain. The structure of IL-5 provides a molecular basis for the design of antagonists and agonists that would delineate receptor recognition determinants critical in signal transduction. This structure determination extends the family of the cytokine bundle of four helices and emphasizes its fundamental significance and versatility in recognizing its receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sanderson, C. J. in Advances in Pharmacology Vol. 23 163–177 (Academic, New York, 1992).
Takatsu, K. Curr. Opin. Immun. 4, 299–306 (1992).
Diederichs, K., Boone, T. & Karplus, P. A. Science 254, 1779–1782 (1991).
Pandit, J. et al. Science 258, 1358–1362 (1992).
Bazan, J. F. & McKay, D. B. Science 257, 410–413 (1992).
Smith, L. J. et al. J. molec. Biol. 224, 899–904 (1992).
de Vos, A. M., Ultsch, M. & Kossiakoff, A. A. Science 255, 306–312 (1992).
Abdel-Meguid, S. S. et al. Proc natn. Acad. Sci. U.S.A. 84, 6434–6439 (1990).
Proudfoot, A. E. I., Fattah, D., Kawashima, E. H., Bernard, A. & Wingfield, P. T. J. Biochem. 270, 357–361 (1990).
Hassell, A. M. et al. J. molec. Biol. 229, 1150–1152 (1993).
Minamitake, Y. et al. J. Biochem. 107, 292–297 (1990).
Proudfoot, A. E. I., Davies, J. G., Turcatti, G. & Wingfield, P. T. FEBS Lett. 283, 61–64 (1990).
Clore, G. M., Apella, E., Yamada, M., Matsushima, K. & Gronenborn, A. M. Biochemistry 29, 1689–1696 (1990).
Ealick, S. E. et al. Science 252, 698–702 (1991).
Takahashi, T. et al. Molec. Immun. 9, 911–920 (1990).
McKenzie, A. N. J., Ely, B. & Sanderson, C. J. Molec. Immun. 28, 155–158 (1991).
Parry, D. A. D., Minasian E. & Leach, S. J. J. molec. Recgn 1, 107–110 (1988).
Bazan, J. F. Proc. natn. Acad. Sci. U.S.A. 87, 6934–6938 (1990).
Presnell, S. R. & Cohen, F. E. Proc. natn. Acad. Sci. U.S.A. 86, 6592–6596 (1989).
Miyajima, A., Kitamura, T., Harada, N., Yokota, T. & Arai, K.-I. A. Rev. Immun. 10, 295–311 (1992).
Arai, K.-I. et al. A. Rev. Biochem. 59, 783–836 (1990).
Takatsu, K. Microbiol. Immun. 35, 593–606 (1991).
McKenzie, A. N. J., Barry, S. C., Strath, M. & Sanderson, C. J. EMBO J. 10, 1193–1199 (1991).
Kodama, S., Tsuruoka, N. & Tsujimoto, M. Biochem. Biophys. Res. Commun. 178, 514–519 (1991).
Lambert, M. H. & Scheraga, H. A. J. comp. Chem. 10, 770–797 (1989).
Needleman, C. D. & Wunsch, C. D. J. molec. Biol. 48, 443–453 (1970).
Fun, G. et al. Science 256, 1677–1680 (1992).
Howard, A. J. et al. J. appl. Crystallogr. 20, 383–403 (1987).
Furey, W. & Swaminathan, S. Am. crystallogr. Assoc. Mtg Abstr. Ser. 2 18, 73 (1990).
Terwilliger, T., Kim, S.-H. & Eisenberg, D. Acta crystallogr. A43, 1 (1987).
Jones, A. T. Meth. Enzym. 115, 157–171 (1985).
Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458–460 (1987).
Gonnet, G. H., Cohen, M. A. & Benner, S. A. Science 256, 1443–1445 (1992).
Kraulis, P. J. J. appl. Crystallogr. 24, 246–250 (1991).
Brünger, A. T. Nature 355, 472–475 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Milburn, M., Hassell, A., Lambert, M. et al. A novel dimer configuration revealed by the crystal structure at 2.4 Å resolution of human interleukin-5. Nature 363, 172–176 (1993). https://doi.org/10.1038/363172a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/363172a0
This article is cited by
-
Structural and evolutionary exploration of the IL-3 family and its alpha subunit receptors
Amino Acids (2021)
-
Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy
Current Allergy and Asthma Reports (2016)
-
Identification of interleukin genes in Pogona vitticeps using a de novo transcriptome assembly from RNA-seq data
Immunogenetics (2016)
-
Cytokines in Common Variable Immunodeficiency as Signs of Immune Dysregulation and Potential Therapeutic Targets – A Review of the Current Knowledge
Journal of Clinical Immunology (2014)
-
Insufficient (Sub-native) Helix Content in Soluble/Solid Aggregates of Recombinant and Engineered Forms of IL-2 Throws Light on How Aggregated IL-2 is Biologically Active
The Protein Journal (2012)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.